Cargando…
Glucose lowering effect of transgenic human insulin-like growth factor-I from rice: in vitro and in vivo studies
BACKGROUND: Human insulin-like growth factor-I (hIGF-I) is a growth factor which is highly resemble to insulin. It is essential for cell proliferation and has been proposed for treatment of various endocrine-associated diseases including growth hormone insensitivity syndrome and diabetes mellitus. I...
Autores principales: | Cheung, Stanley CK, Liu, Li-zhong, Lan, Lin-lin, Liu, Qiao-quan, Sun, Samuel SM, Chan, Juliana CN, Tong, Peter CY |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098155/ https://www.ncbi.nlm.nih.gov/pubmed/21486461 http://dx.doi.org/10.1186/1472-6750-11-37 |
Ejemplares similares
-
What can we learn from the recent blood glucose lowering megatrials?
por: Chan, Juliana CN
Publicado: (2011) -
Methazolamide Is a New Hepatic Insulin Sensitizer That Lowers Blood Glucose In Vivo
por: Konstantopoulos, Nicky, et al.
Publicado: (2012) -
Manipulation of the Rice L-Galactose Pathway: Evaluation of the Effects of Transgene Overexpression on Ascorbate Accumulation and Abiotic Stress Tolerance
por: Zhang, Gui-Yun, et al.
Publicado: (2015) -
Inhibition of Human MCF-7 Breast Cancer Cells and HT-29 Colon Cancer Cells by Rice-Produced Recombinant Human Insulin-Like Growth Binding Protein-3 (rhIGFBP-3)
por: Cheung, Stanley C. K., et al.
Publicado: (2013) -
The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs
por: Kalra, Sanjay, et al.
Publicado: (2016)